AGM/EGMApr 30, 2026, 04:35 PM
OSUR 2026 Annual Meeting: Board Declassification, Stock Plan Increase
AI Summary
OraSure Technologies, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 3, 2026. Key proposals include the declassification of the Board of Directors and an amendment to the Stock Award Plan to increase authorized shares by 5 million and extend its term by ten years. The company highlighted strong 2025 performance, including $19 million in cost savings, a strong balance sheet with $199 million in cash, and $15 million returned to shareholders through buybacks, alongside key FDA submissions and an acquisition.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 3, 2026, at 9:00 a.m. ET.
- Proposing amendment to Certificate of Incorporation to declassify Board over three-year period.
- Seeking approval to increase Stock Award Plan shares by 5,000,000 and extend its term by ten years.
- 2025: Achieved $19 million in annualized run rate cost savings.
- 2025: Ended year with approximately $199 million in cash and no debt.
- 2025: Returned $15 million to stockholders through repurchase of 5.3 million shares.
- 2025: Total net revenue of $115 million.
- Submitted FDA 510(k) for Sherlock CT/NG rapid molecular self-test and Colli-Pee urine collection device in Dec 2025.
- Acquired BioMedomics, Inc. in Nov 2025, adding SickleSCAN rapid point-of-care test.